PGx Multi tests
Broad pharmacogenomic test covering mental health, pain, cardiology and additional medications.

Test description

The PGx Multi test analyses variations in genes that have been shown to influence drug response and metabolism for over 100 medications used commonly in clinical practice including medications used in mental health, pain, cardiology, gastroenterology and more.

The report provides medication-specific prescribing considerations to help improve the safety and efficacy of medications and reduce the risk of unwanted side effects.

Test Name PGx Multi
Clinical Indication To determine optimal medication and dosage for multiple pharmaceutical agents
Gene(s) CYP2D6*2, *3, *4, *5, *6, *7, *8, *9, *10, *14A, *14B, *17, *29, *36, *41; CYP2C19*2, *3, *17; CYP2C9*2, *3; CYP1A2*1F; CYP3A4*22; CYP3A5*3; SLCOB1, VKORC1, OPRM1, ABCG2 and CYPB26
Method PCR Genotyping
Turn around time 2 weeks from sample receipt
Medicare Eligibility No
Price $197
Test Request Form Standard pathology request form
Collection Requirements 6mL EDTA tube
Special Instructions Please specify the medications of interest on the request form
Links RCPA Guidance

Test information

Test name
Clinical indication
Gene(s)
Method
Turn around time
Medicare eligibility
Price
Test request form
Sample type
Collection type
Special instructions
Genetic tests
Non-Invasive Prenatal Test (NIPT)Expanded Genetic Carrier ScreeningPharmacogenomicsHereditary & Ovarian Breast CancerInherited Colorectal Cancer Syndromes
Clinical information
Genetic counsellingTesting guideLaboratory locationsRequest forms
About
About us Our peopleContact
© 2025 Healius Limited
Disclaimer & termsPrivacy policyCopyright noticeUptime